EVELO BIOSCIENCES INC by Evelo Biosciences, Inc. Analyst Price Targets - Benzinga

EVELO BIOSCIENCES INC by Evelo Biosciences, Inc.

EVLOOTCEM

Trade with Public

Trade with Public

$0.3165

-0.0535-14.46%

At close: Dec 8, 4:00 PM EST

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Compare

EVELO BIOSCIENCES INC by Evelo Biosciences, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for EVELO BIOSCIENCES INC by Evelo Biosciences, Inc. (EVLO).

Analyst Consensus — 1 Analysts

1Hold

# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 18, 2023	TD Cowen	Joseph Thome	Downgrade	Outperform→Market Perform	—

Analyst Ratings News

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023

Benzinga Insights

PRO
TD Cowen Downgrades Evelo Biosciences to Market Perform

TD Cowen analyst Joseph Thome downgrades Evelo Biosciences (NASDAQ:EVLO) from Outperform to Market Perform.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Raises Price Target to $10

Morgan Stanley analyst Vikram Purohit maintains Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight and raises the price target from $2 to $10.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Lowers Price Target to $2

Morgan Stanley analyst Vikram Purohit maintains Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight and lowers the price target from $4 to $2.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022

Benzinga Insights

PRO
Chardan Capital Downgrades Evelo Biosciences to Neutral, Announces $2.5 Price Target

Chardan Capital analyst Keay Nakae downgrades Evelo Biosciences (NASDAQ:EVLO) from Buy to Neutral and announces $2.5 price target.

Benzinga Newsdesk